The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
about
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 DiabetesDiabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survivalBasal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision makingDiabetic kidney disease: a report from an ADA Consensus ConferenceUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes MellitusGenetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial.Therapeutic management of diabetic kidney disease.Diabetes in older adultsGender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials.Optimal therapy of type 2 diabetes: a controversial challengeLow socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE).Long-term effects of intensive glucose lowering on cardiovascular outcomes.Diabetes in the elderly.Diabetes. Can tight glycemic control in diabetes benefit cognition?National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial dataDiabetes in older adults: a consensus reportCounterpoint: Intensive glucose control and mortality in ACCORD--still looking for cluesPathophysiology and treatment of diabetic retinopathy.Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitusRecognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitusAustralian Nurse Practitioner Practice: Value Adding through Clinical Reflexivity.Cardiovascular disease in diabetes: where does glucose fit in?Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetesSex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy).Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORDAcute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease.Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trialPredictors for Mild and Severe Hypoglycemia in Insulin-Treated Japanese Diabetic Patients.Metabolic memory and individual treatment aims in type 2 diabetes--outcome-lessons learned from large clinical trials.Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trialImpact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes.Management of Hyperglycemia in Diabetic Kidney Disease.Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial.Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitusAssociation of hypoglycemia with incident chronic kidney disease in patients with type 2 diabetes: a nationwide population-based studySurvey of Hypoglycemia in Elderly People With Type 2 Diabetes Mellitus in Japan.Death during intensive glycemic therapy of diabetes: mechanisms and implications.
P2860
Q26767283-844DC7BE-728B-4A3D-A540-AD9A3FB075F4Q26827620-6FC36F34-9021-4839-BBA8-E251ACF28623Q26992979-365E53AC-1642-43A1-A755-0D45EA3341E0Q27012546-0C9FC714-D767-4CFB-9B48-1D22832A81D0Q27687851-A9725C45-5751-4B8E-9BF1-C8D3899C97A0Q28072980-FABFD4ED-9681-4D0B-BAB7-452FCE69BBC1Q30276113-15F13FAA-03FA-47F2-ADE8-C2475B9E5CCCQ30362729-8380DDFA-6EAF-43B4-9A0B-F5FAE31B6EBBQ30528669-BBCE43B6-4076-4ED4-8C8A-5BBC5A2B45A3Q30891945-59DF3C32-9D77-4BDD-BD7D-E3D5B1058CE9Q33577712-859D8EF1-CD8B-4AB2-BC54-6ACACA618CC0Q33664937-F355AB85-DFA6-42D8-99D7-C4557AF34705Q33851861-58A08F5F-B0D7-4764-B64E-8C2F9352E90FQ33903514-A713C4CE-B0EA-434B-86BF-5DDBDF278346Q33915696-625A7F0A-B211-45B9-8F57-1ADC2C48AD7AQ34122776-89690DAA-B9B8-49EE-AB44-E4AE1F28205DQ34286013-08160557-BA22-438D-9096-7EE018EBAFB7Q34308751-03B60B1A-09AC-4C21-927E-6F63790651B0Q34351961-8B1B80C4-2CEC-4642-9384-1D6BA2B5C91BQ34528134-B1299331-061D-46F9-9B96-0C7E79012629Q34701421-EAB548EC-8CE7-4F07-BC93-18D87639C299Q34887952-64B14498-791B-464B-BF50-B550072BE9D7Q35075299-C8242119-A4A1-4B88-A7C3-508759A4E2A1Q35137148-3C3AC811-9F1C-4490-A5D4-E5F9D758F428Q35179251-E0865825-8AD8-4F06-BA66-415A814688E0Q35271574-2414F1D2-C496-46EB-BAC0-18BA327A06FBQ35561497-B5EE679B-AF91-49B1-8CF3-EA3ADB8C2B7FQ35573137-69B35808-D8C0-41C6-A8BF-EF5C514D45BDQ35592044-12EDD6CE-592A-4AF7-9A15-B257876479DBQ35630701-FFF1209C-6ECA-460F-9881-A7B15A0C743EQ35671692-8480AEE3-63C9-4C96-B193-37F5565337F4Q35760316-0A05EC0E-8E37-4644-B1F1-49FAD31B9869Q35841183-16BE2627-F41E-461B-815F-0CA812767757Q35898351-0EF11EBB-4CC8-4455-8012-ADE4BA978167Q35953856-93F7F1EB-FDF4-4F1E-B5DB-B2330AA244FBQ36047231-ADF4F4C0-A1AE-47A6-88DB-C36AF747BA41Q36082257-A5D9238F-F52B-45DD-9364-E1049D2C8EEDQ36152043-A9DA338C-A038-4FE2-8649-D0B0B41512AEQ36223763-8349FE5F-900A-418D-8A95-FCE4A598196FQ36297059-0BD434AB-3BFD-40CC-848F-417EEB43F985
P2860
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The effects of baseline charac ...... analysis of the ACCORD study.
@ast
The effects of baseline charac ...... analysis of the ACCORD study.
@en
The effects of baseline charac ...... analysis of the ACCORD study.
@nl
type
label
The effects of baseline charac ...... analysis of the ACCORD study.
@ast
The effects of baseline charac ...... analysis of the ACCORD study.
@en
The effects of baseline charac ...... analysis of the ACCORD study.
@nl
prefLabel
The effects of baseline charac ...... analysis of the ACCORD study.
@ast
The effects of baseline charac ...... analysis of the ACCORD study.
@en
The effects of baseline charac ...... analysis of the ACCORD study.
@nl
P2093
P2860
P356
P1433
P1476
The effects of baseline charac ...... l analysis of the ACCORD study
@en
P2093
ACCORD Investigators
Denise E Bonds
Elizabeth R Seaquist
Farmarz Ismail-Beigi
George Dailey
Joe F Largay
Jorge Calles-Escandon
Mark N Feinglos
Michael E Miller
P2860
P356
10.1136/BMJ.B5444
P407
P577
2010-01-08T00:00:00Z